Literature DB >> 2407557

Monoclonal antibodies against the presynaptic calcium channel antagonist omega-conotoxin GVI A from cone snail poison.

D Tombaccini1, O M Adeyemo, H B Pollard, G Feuerstein.   

Abstract

Monoclonal antibodies have been prepared against omega-conotoxin GVI A, a peptide isolated from marine snails of the genus Conus (Conus geographus and Conus magus). This toxin is a blocker of select presynaptic Ca2+ channels in the central nervous system. Antigenic omega-conotoxin GVI A was synthesized as a covalent conjugate with bovine serum albumin and injected s.c. An ELISA assay combined with a competitive inhibition assay was used to select and characterize monoclonal antibodies able to recognize and bind the free toxin. Several of the antibodies were found to block omega-conotoxin GVI A inhibition of 45Ca transport into rat brain synaptosomes and to block omega-conotoxin GVI A binding to membranes from the same preparation. The antibodies recognize native, synthetic toxin, and are useful for analysis of toxin in biological fluids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407557     DOI: 10.1016/0014-5793(90)80639-z

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Characterization of alpha-conotoxin interactions with the nicotinic acetylcholine receptor and monoclonal antibodies.

Authors:  J D Ashcom; B G Stiles
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

2.  Preparation and identification of monoclonal antibodies against ω-conotoxin MVIIA.

Authors:  Yanling Yang; Yanling Ma; Heng Li; Shihua Wang; Zhenhong Zhuang
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08

3.  Antigen selectivity characteristic of polyclonal antibodies against omega-conotoxin GVIA and N-type voltage-dependent calcium channels.

Authors:  S Ichida; J Abe; W Sugimoto; M Uematsu; K Komoike; K Imoto; M Mori; T Wada; T Minami; K Kakutani
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.